These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
190 related items for PubMed ID: 1290288
21. Model systems for the discovery and development of antiarrhythmic drugs. Nattel S, Duker G, Carlsson L. Prog Biophys Mol Biol; 2008; 98(2-3):328-39. PubMed ID: 19038282 [Abstract] [Full Text] [Related]
22. The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. Eur Heart J; 1991 Oct; 12(10):1112-31. PubMed ID: 1723682 [Abstract] [Full Text] [Related]
23. [Ischemic disorders of cardiac rhythm: effects of the autonomic nervous system on electrophysiologic findings and pharmacotherapy]. Gülker H, Thale J. Z Kardiol; 1986 Oct; 75 Suppl 5():15-34. PubMed ID: 3825228 [Abstract] [Full Text] [Related]
24. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome. Milberg P, Tegelkamp R, Osada N, Schimpf R, Wolpert C, Breithardt G, Borggrefe M, Eckardt L. J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304 [Abstract] [Full Text] [Related]
25. [The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor]. Sokolov SF, Golitsyn SP, Malakhov VI, Bankuzov VA, Koltunova MI, Golitsyn LS. Farmakol Toksikol; 1990 Jun; 53(3):57-60. PubMed ID: 2387385 [Abstract] [Full Text] [Related]
28. Evolution, mechanisms, and classification of antiarrhythmic drugs: focus on class III actions. Nattel S, Singh BN. Am J Cardiol; 1999 Nov 04; 84(9A):11R-19R. PubMed ID: 10568655 [Abstract] [Full Text] [Related]
29. Rate dependence of the effect of antiarrhythmic drugs delaying cardiac repolarization: an overview. Dorian P, Newman D. Europace; 2000 Oct 04; 2(4):277-85. PubMed ID: 11194593 [Abstract] [Full Text] [Related]
30. Class IB antiarrhythmic drugs: tocainide, mexiletine, and moricizine. Snyder DW. J La State Med Soc; 1989 May 04; 141(5):21-5. PubMed ID: 2499645 [Abstract] [Full Text] [Related]
31. Current clinical perspectives on antiarrhythmic drug therapy. Anderson JL. Fed Proc; 1986 Jul 04; 45(8):2213-9. PubMed ID: 3720963 [Abstract] [Full Text] [Related]
32. Update on antiarrhythmic drug pharmacology. Huang CL, Wu L, Jeevaratnam K, Lei M. J Cardiovasc Electrophysiol; 2020 Feb 04; 31(2):579-592. PubMed ID: 31930579 [Abstract] [Full Text] [Related]
38. Mechanisms of action of class III agents and their clinical relevance. Dorian P. Europace; 2000 Jul 30; 1 Suppl C():C6-9. PubMed ID: 11220521 [Abstract] [Full Text] [Related]